Naftifine Hydrochloride

CAS 65473-14-5 7 current recordsSmall Molecule

Who holds supplier records for Naftifine Hydrochloride? 7 organisations hold a current record for Naftifine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Italy (2), India (1) and Israel (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Naftifine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/naftifine-hydrochloride

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Naftifine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Italy2India1Israel1Country not recorded for 3
  • CHONGQING HUAPONT PHARMACEUTICAL CO LTD
    Active DMF 28735 · latest filing Aug 2014
  • ERREGIERRE SPA
    Active DMF 14711 · latest filing Feb 2000
    Italy Company GMP cert on record
  • MSN Laboratories Private Limited
    Active DMF 28931 · latest filing Jan 2015
    India Company GMP cert on record
  • NOVARTIS PHARMA AG
    Active DMF 16772 · latest filing Aug 2003
    Company GMP cert on record
  • OLON SPA
    Active DMF 18147 · latest filing Mar 2005
    Italy Company GMP cert on record
  • SHANGHAI ZIYUAN PHARMACEUTICAL CO LTD
    Active DMF 23456 · latest filing Aug 2010
  • Taro Pharmaceutical Industries Ltd.
    Active DMF 24619 · latest filing Jun 2012
    Israel Company GMP cert on record
Need Naftifine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Naftifine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200493).

Chemical identity

IUPAC name
(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;hydrochloride
Canonical SMILES
CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl
InChIKey
OLUNPKFOFGZHRT-YGCVIUNWSA-N
Synonyms
AW 105-843, NAFT-900, NAFT900, Naftifine hcl, Naftifine hydrochloride, Naftin, NSC-760068, Exoderil, SN 105843, RefChem:57002, Naftifungin, AW 105843

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Allylamine Antifungal
Chemical structure
Allylamine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Naftifine Hydrochloride?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Naftifine Hydrochloride: CHONGQING HUAPONT PHARMACEUTICAL CO LTD, ERREGIERRE SPA (Italy), MSN Laboratories Private Limited (India), NOVARTIS PHARMA AG, OLON SPA (Italy), SHANGHAI ZIYUAN PHARMACEUTICAL CO LTD and Taro Pharmaceutical Industries Ltd. (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Naftifine Hydrochloride Drug Master Files are active?

CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 28735), ERREGIERRE SPA (DMF 14711), MSN Laboratories Private Limited (DMF 28931), NOVARTIS PHARMA AG (DMF 16772), OLON SPA (DMF 18147), SHANGHAI ZIYUAN PHARMACEUTICAL CO LTD (DMF 23456) and Taro Pharmaceutical Industries Ltd. (DMF 24619). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Naftifine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Naftifine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.